相似文献
1
Binding of sulfamethazine to β-cyclodextrin and methyl-β-cyclodextrin.
AAPS PharmSciTech. 2013 Jun;14(2):727-35. doi: 10.1208/s12249-013-9958-9. Epub 2013 Apr 19.
2
Sulfamethoxazole:hydroxypropyl-β-cyclodextrin complex: preparation and characterization.
J Pharm Biomed Anal. 2012 Apr 7;63:74-9. doi: 10.1016/j.jpba.2012.01.011. Epub 2012 Feb 2.
3
Solubility and release modulation effect of sulfamerazine ternary complexes with cyclodextrins and meglumine.
J Pharm Biomed Anal. 2014 Nov;100:64-73. doi: 10.1016/j.jpba.2014.07.008. Epub 2014 Jul 30.
4
Improvement of aripiprazole solubility by complexation with (2-hydroxy)propyl-β-cyclodextrin using spray drying technique.
AAPS PharmSciTech. 2012 Jun;13(2):623-31. doi: 10.1208/s12249-012-9786-3. Epub 2012 Apr 26.
5
Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin.
Eur J Pharm Biopharm. 2007 Sep;67(2):531-9. doi: 10.1016/j.ejpb.2007.03.005. Epub 2007 Mar 13.
6
Preparation and solid-state characterization of inclusion complexes formed between miconazole and methyl-beta-cyclodextrin.
AAPS PharmSciTech. 2008;9(4):1102-9. doi: 10.1208/s12249-008-9143-8. Epub 2008 Oct 31.
7
Physicochemical, in silico and in vivo evaluation of a danazol-beta-cyclodextrin complex.
Int J Pharm. 2008 Mar 20;352(1-2):5-16. doi: 10.1016/j.ijpharm.2007.10.005. Epub 2007 Oct 13.
8
Preparation and solid-state characterization of bupivacaine hydrochloride cyclodextrin complexes aimed for buccal delivery.
J Pharm Biomed Anal. 2010 May 1;52(1):9-18. doi: 10.1016/j.jpba.2009.11.013. Epub 2009 Nov 18.
9
Physicochemical characterization of efavirenz-cyclodextrin inclusion complexes.
AAPS PharmSciTech. 2009;10(1):81-7. doi: 10.1208/s12249-008-9180-3. Epub 2009 Jan 16.
10
Analysis of triclosan inclusion complexes with β-cyclodextrin and its water-soluble polymeric derivative.
J Pharm Biomed Anal. 2011 Apr 5;54(5):1030-9. doi: 10.1016/j.jpba.2010.12.009. Epub 2010 Dec 16.
引用本文的文献
1
Enhancing Permanence of Corrosion Inhibitors Within Acrylic Protective Coatings for Outdoor Bronze Using Green Nanocontainers.
Molecules. 2024 Dec 3;29(23):5702. doi: 10.3390/molecules29235702.
2
Silver-Sulfamethazine-Conjugated β-Cyclodextrin/Dextran-Coated Magnetic Nanoparticles for Pathogen Inhibition.
Nanomaterials (Basel). 2024 Feb 17;14(4):371. doi: 10.3390/nano14040371.
3
Adsorption of Sulfamethazine Drug onto the Modified Derivatives of Carbon Nanotubes at Different pH.
Molecules. 2020 May 27;25(11):2489. doi: 10.3390/molecules25112489.
4
Thermodynamic Characterization of the Interaction between the Antimicrobial Drug Sulfamethazine and Two Selected Cyclodextrins.
Molecules. 2019 Dec 13;24(24):4565. doi: 10.3390/molecules24244565.
5
Cyclodextrin-promoted Diels Alder reactions of a polycyclic aromatic hydrocarbon under mild reaction conditions.
Tetrahedron Lett. 2015 Mar 1;56(13):1619-1623. doi: 10.1016/j.tetlet.2015.01.185. Epub 2015 Feb 9.
6
Characterization of albendazole-randomly methylated-β-cyclodextrin inclusion complex and in vivo evaluation of its antihelmitic activity in a murine model of Trichinellosis.
PLoS One. 2014 Nov 18;9(11):e113296. doi: 10.1371/journal.pone.0113296. eCollection 2014.
7
Increasing doxycycline hyclate photostability by complexation with β-cyclodextrin.
AAPS PharmSciTech. 2014 Oct;15(5):1209-17. doi: 10.1208/s12249-014-0150-7. Epub 2014 Jun 3.
本文引用的文献
1
Complexation of carbendazim with hydroxypropyl-β-cyclodextrin to improve solubility and fungicidal activity.
Carbohydr Polym. 2012 Jun 5;89(1):208-12. doi: 10.1016/j.carbpol.2012.02.072. Epub 2012 Mar 7.
2
Sulfamethoxazole:hydroxypropyl-β-cyclodextrin complex: preparation and characterization.
J Pharm Biomed Anal. 2012 Apr 7;63:74-9. doi: 10.1016/j.jpba.2012.01.011. Epub 2012 Feb 2.
3
Hollow fiber-based liquid phase microextraction (HF-LPME) for a highly sensitive HPLC determination of sulfonamides and their main metabolites.
J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Jan 15;879(2):197-204. doi: 10.1016/j.jchromb.2010.12.006. Epub 2010 Dec 13.
4
Pharmaceutical applications of cyclodextrins: basic science and product development.
J Pharm Pharmacol. 2010 Nov;62(11):1607-21. doi: 10.1111/j.2042-7158.2010.01030.x.
5
Complexation of sulfonamides with beta-cyclodextrin studied by experimental and theoretical methods.
J Pharm Sci. 2010 Jul;99(7):3166-76. doi: 10.1002/jps.22062.
6
An efficient ternary complex of acetazolamide with HP-ss-CD and TEA for topical ocular administration.
J Control Release. 2009 Aug 19;138(1):24-31. doi: 10.1016/j.jconrel.2009.04.035. Epub 2009 May 6.
7
Development and validation of a confirmatory method for the determination of sulphonamides in milk by liquid chromatography with diode array detection.
Anal Chim Acta. 2009 Apr 1;637(1-2):18-23. doi: 10.1016/j.aca.2008.09.022. Epub 2008 Sep 16.
8
The influence of the preparation methods on the inclusion of model drugs in a beta-cyclodextrin cavity.
Eur J Pharm Biopharm. 2009 Feb;71(2):377-86. doi: 10.1016/j.ejpb.2008.09.027. Epub 2008 Oct 17.
9
Development of flow-through and dip-stick immunoassays for screening of sulfonamide residues.
J Immunol Methods. 2008 Aug 20;337(1):1-6. doi: 10.1016/j.jim.2008.04.015. Epub 2008 May 27.
10
Optimization of a FIA system with amperometric detection by means of a desirability function: determination of sulfadiazine, sulfamethazine and sulfamerazine in milk.
Talanta. 2008 Mar 15;75(1):274-83. doi: 10.1016/j.talanta.2007.11.030. Epub 2007 Nov 17.
Zotero 插件